Trexquant Investment LP Sells 73,233 Shares of Select Medical Holdings Corporation $SEM

Key Points

• Trexquant Investment LP has reduced its stake in Select Medical Holdings Corporation by 50.5%, selling 73,233 shares and now owns approximately 0.06% of the company valued at $1.2 million.
• Several institutional investors have increased their holdings in Select Medical, with Price T Rowe Associates and Vanguard Group among those significantly enhancing their positions.
• Select Medical reported earnings per share of $0.32 for the last quarter, exceeding analysts' expectations, while the company also declared a quarterly dividend of $0.0625 per share.

Trexquant Investment LP trimmed its stake in shares of Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 50.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 71,880 shares of the health services provider's stock after selling 73,233 shares during the period. Trexquant Investment LP owned about 0.06% of Select Medical worth $1,200,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Caitong International Asset Management Co. Ltd raised its holdings in shares of Select Medical by 61.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 2,703 shares of the health services provider's stock worth $45,000 after acquiring an additional 1,030 shares during the period. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of Select Medical during the first quarter worth $60,000. GAMMA Investing LLC lifted its position in shares of Select Medical by 217.4% in the first quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock worth $109,000 after purchasing an additional 4,453 shares in the last quarter. Lazard Asset Management LLC lifted its position in shares of Select Medical by 47.8% in the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock worth $130,000 after purchasing an additional 2,255 shares in the last quarter. Finally, Wealthquest Corp bought a new stake in shares of Select Medical in the first quarter worth $143,000. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently commented on the stock. UBS Group reissued a "neutral" rating and issued a $14.00 price objective (down previously from $15.00) on shares of Select Medical in a research report on Monday, August 4th. Bank of America cut their price objective on shares of Select Medical from $18.00 to $15.00 and set a "buy" rating on the stock in a research report on Wednesday. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $19.20.

Select Medical Stock Performance

NYSE SEM traded down $0.28 on Friday, hitting $12.53. 489,877 shares of the stock were exchanged, compared to its average volume of 857,438. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.15 and a quick ratio of 1.15. The business's fifty day moving average is $13.41 and its 200 day moving average is $15.12. Select Medical Holdings Corporation has a 52 week low of $11.65 and a 52 week high of $40.98. The company has a market capitalization of $1.55 billion, a PE ratio of 11.82, a P/E/G ratio of 0.52 and a beta of 1.25.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The health services provider reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.04. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The firm had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same period in the prior year, the firm posted $0.60 earnings per share. The company's quarterly revenue was up 4.5% compared to the same quarter last year. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Research analysts anticipate that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.

Select Medical Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th were given a $0.0625 dividend. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.25 annualized dividend and a dividend yield of 2.0%. Select Medical's dividend payout ratio is presently 23.58%.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.